Surface Oncology, Inc. Annual Return On Equity in % from 2018 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Surface Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2022.
  • Surface Oncology, Inc. Return On Equity for the quarter ending June 30, 2023 was -112 %, a 132% decline year-over-year.
  • Surface Oncology, Inc. annual Return On Equity for 2022 was -53.1 %, a 5.73% increase from 2021.
  • Surface Oncology, Inc. annual Return On Equity for 2021 was -56.3 %, a 200% decline from 2020.
  • Surface Oncology, Inc. annual Return On Equity for 2020 was 56.4 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -53.1 +3.23 +5.73% Jan 1, 2022 Dec 31, 2022
2021 -56.3 -113 -200% Jan 1, 2021 Dec 31, 2021
2020 56.4 +127 Jan 1, 2020 Dec 31, 2020
2019 -70.6 -62.1 -729% Jan 1, 2019 Dec 31, 2019
2018 -8.52 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.